1) PCT/IL2007/001300 (WO 2008/050344)) the use of CB1- and CB2- ligands for the treatment of hepatic encephalopathy in the respective experimental model.
2) PCT/IB2008/003493 (20/11/2008), GR. 20070100697 (20/11/2007), UK. 0724878.4 (20/12/2007), UK. 0810553.8 (09/06/2008), AUSTRALIAN 2008904757 (12/11/2008) “Immunotherapy of Multiple Sclerosis”.